The Latest Headlines at American Banking and Market News
MFA Financial, Inc. (NYSE:MFA) Given Average Recommendation of “Moderate Buy” by Brokerages
MFA Financial, Inc. (NYSE:MFA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the six analysts that are presently covering the company, MarketBeat Ratings reports. Two research... More of this article »
Tecnoglass Inc. (NASDAQ:TGLS) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Tecnoglass Inc. (NASDAQ:TGLS – Get Free Report) has received a consensus rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock... More of this article »
Desjardins Analysts Reduce Earnings Estimates for WSP Global Inc. (TSE:WSP)
WSP Global Inc. (TSE:WSP – Free Report) – Analysts at Desjardins dropped their Q2 2024 earnings per share estimates for WSP Global in a report issued on Thursday, May 9th. Desjardins analyst B. Poirier now forecasts... More of this article »
Atb Cap Markets Analysts Cut Earnings Estimates for Stantec Inc. (TSE:STN)
Stantec Inc. (TSE:STN – Free Report) (NYSE:STN) – Equities researchers at Atb Cap Markets decreased their Q2 2024 earnings per share estimates for Stantec in a report released on Thursday, May 9th. Atb Cap Markets analyst... More of this article »
Q2 2024 EPS Estimates for SmartCentres Real Estate Investment Trst (TSE:SRU) Lowered by Analyst
SmartCentres Real Estate Investment Trst (TSE:SRU – Free Report) – Equities researchers at Desjardins dropped their Q2 2024 earnings per share estimates for shares of SmartCentres Real Estate Investment Trst in a research... More of this article »
Q2 2024 Earnings Estimate for Stantec Inc. Issued By Desjardins (TSE:STN)
Stantec Inc. (TSE:STN – Free Report) (NYSE:STN) – Analysts at Desjardins increased their Q2 2024 earnings per share estimates for Stantec in a research report issued on Thursday, May 9th. Desjardins analyst B. Poirier... More of this article »
Q2 2024 EPS Estimates for Spin Master Corp. (TSE:TOY) Decreased by Analyst
Spin Master Corp. (TSE:TOY – Free Report) – Analysts at National Bank Financial decreased their Q2 2024 earnings estimates for shares of Spin Master in a research note issued to investors on Wednesday, May 8th. National... More of this article »
National Bank Financial Weighs in on WSP Global Inc.’s Q2 2024 Earnings (TSE:WSP)
WSP Global Inc. (TSE:WSP – Free Report) – Investment analysts at National Bank Financial dropped their Q2 2024 earnings per share (EPS) estimates for WSP Global in a research report issued to clients and investors on... More of this article »
Q2 2024 Earnings Estimate for Stelco Holdings Inc. Issued By National Bank Financial (TSE:STL)
Stelco Holdings Inc. (TSE:STL – Free Report) – Equities researchers at National Bank Financial cut their Q2 2024 earnings estimates for Stelco in a research note issued to investors on Thursday, May 9th. National Bank... More of this article »
Desjardins Brokers Reduce Earnings Estimates for TELUS Co. (TSE:T)
TELUS Co. (TSE:T – Free Report) (NYSE:TU) – Investment analysts at Desjardins decreased their Q2 2024 EPS estimates for TELUS in a research note issued to investors on Thursday, May 9th. Desjardins analyst J. Dubreuil... More of this article »
Raymond James Equities Analysts Boost Earnings Estimates for WSP Global Inc. (TSE:WSP)
WSP Global Inc. (TSE:WSP – Free Report) – Research analysts at Raymond James raised their Q2 2024 earnings per share estimates for shares of WSP Global in a research report issued on Thursday, May 9th. Raymond James... More of this article »
National Bank Financial Research Analysts Raise Earnings Estimates for Sleep Country Canada Holdings Inc. (TSE:ZZZ)
Sleep Country Canada Holdings Inc. (TSE:ZZZ – Free Report) – Stock analysts at National Bank Financial increased their Q2 2024 earnings per share (EPS) estimates for shares of Sleep Country Canada in a research note... More of this article »
William Blair Comments on Tarsus Pharmaceuticals, Inc.’s Q2 2024 Earnings (NASDAQ:TARS)
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) – Equities research analysts at William Blair boosted their Q2 2024 EPS estimates for Tarsus Pharmaceuticals in a research note issued on Wednesday, May 8th.... More of this article »